Main Topic Area
All Topic Areas
1 - 10 of 13 more >>
News
1 - 5 of 8 more >>
- Interim Analysis Of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels Of HIV Suppression To Boosted Lopinavir
MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
- Roche To Transfer Technology For Protease Inhibitor Saquinavir To Three Generic Drug Companies In Sub-Saharan Africa
MedicalNewsToday - Wed, 27 Sep 2006 02:00 EST
- First Technology Transfers From Roche To Enable Local Production Of HIV Medicine For Africa
MedicalNewsToday - Mon, 25 Sep 2006 07:00 EST
- Roche To Transfer Technology For Protease Inhibitor Saquinavir To Generic Drug Companies In Developing Countries
MedicalNewsToday - Fri, 13 Jan 2006 07:00 EST
- Patients treated with boosted Invirase, a potent anti-HIV treatment, do not develop resistance
MedicalNewsToday - Wed, 27 Jul 2005 11:00 EST
Clinical Trials
1 - 5 of 59 more >>
- A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study
ClinicalTrials.gov Identifier: NCT00192608 - Active, not recruiting
HIV Infections
- A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
ClinicalTrials.gov Identifier: NCT00000913 - Active, not recruiting
HIV Infections
- The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.
ClinicalTrials.gov Identifier: NCT00145561 - Active, not recruiting
HIV Infections
- Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00050180 - Active, not recruiting
Healthy; HIV Infections
- Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
ClinicalTrials.gov Identifier: NCT00084058 - Active, not recruiting
HIV Infections

Not Signed In -

